Evidence map›Paper›PMID 36620621›Full record

ArticleFrontiers in cardiovascular medicine2022

Percutaneous coronary intervention improves quality of life of patients with chronic total occlusion and low estimated glomerular filtration rate.

Shuai Zhao, Yan Chen, Boda Zhu, Jiayi Wang, Zhihong Wei, Yiming Zou, Wentao Hu, Genrui Chen, Huan Wang, Chenhai Xia and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Shuai ZhaoDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Yan ChenDepartment of Cardiology, No. 971 Hospital of the PLA Navy, Qingdao, Shandong, China.
Boda ZhuDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Jiayi WangCadet Brigade, School of Basic Medicine, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Zhihong WeiDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Yiming ZouCadet Brigade, School of Basic Medicine, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Wentao HuCadet Brigade, School of Basic Medicine, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Genrui ChenDepartment of Cardiology, Hanyin County People's Hospital, Ankang, Shaanxi, China.
Huan WangDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Chenhai XiaDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Tiantong YuDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Peng HanDepartment of Cardiology, 981 Hospital of Joint Logistics Support Force, Chengde, Hebei, China.
Li YangDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Wei WangDepartment of Pharmaceutics and Pharmacy Administration, School of Pharmacy, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Zhongjie ZhaiDepartment of Health Statistics, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Haokao GaoDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Chengxiang LiDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Kun LianDepartment of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Air Force Medical University · CNXijing Hospital · CNPeople's Liberation Army 401 Hospital · CNPLA Air Force Aviation University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A low estimated glomerular filtration rate (eGFR <90 mL/min/1.73 m Objectives: The aim of this prospective study was to assess the QOL of CTO patients with low eGFR after successful PCI. Methods: Consecutive patients undergoing elective CTO-PCI were prospectively enrolled and subdivided into four groups: eGFR ≥90 mL/min/1.73 m Results: With the decline of eGFR, CTO patients were more likely to present with comorbidities of hypertension, diabetes, hyperuricemia, and previous stroke, in addition to lower hemoglobin levels and left ventricular ejection fraction ( Conclusion: Successful PCI effectively improved symptoms and QOL of CTO patients with low eGFR.

Indexed as

chronic total occlusionlow estimated glomerular filtration ratepercutaneous coronary interventionquality of lifesymptom

Identifiers

PMID36620621
PMCPMC9812571
OpenAlexW4313466074

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.